-
1
-
-
0020532060
-
Isolation of human T-cell leukemia virus in Aquired Immune Deficiency Syndrome (AIDS)
-
(1983)
Science
, vol.220
, pp. 865-867
-
-
Gallo, R.C.1
Sarin, P.S.2
Gelmann, E.P.3
Robert-Guroff, M.4
Richardson, E.5
Kalyanaraman, V.S.6
Mann, D.7
Sidhu, G.D.8
Stahl, R.E.9
Zolla-Pazner, S.10
Leibowitch, J.11
Popovic, M.12
-
2
-
-
0020596551
-
Isolation of T-lymphotropic retrovirus from a patient at risk for Aquired Immune Deficiency Syndrome (AIDS)
-
(1983)
Science
, vol.220
, pp. 868-871
-
-
Barré-Sinoussi, F.1
Chermann, J.C.2
Rey, F.3
Nugeyre, M.T.4
Chamaret, S.5
Gruest, J.6
Dauguet, C.7
Axlier-Blin, C.8
Vézinet-Brun, F.9
Rouzioux, C.10
Rozenbaum, W.11
Montagnier, L.12
-
3
-
-
0021261510
-
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
-
(1984)
Science
, vol.224
, pp. 500-503
-
-
Gallo, R.C.1
Salahuddin, S.Z.2
Popovic, M.3
Shearer, G.M.4
Kaplan, M.5
Haynes, B.F.6
Palker, T.J.7
Redfield, R.8
Oleske, J.9
Safai, B.10
White, G.11
Foster, P.12
Markham, P.D.13
-
5
-
-
0023052240
-
Isolation of a new human retrovirus from West African patients with AIDS
-
(1986)
Science
, vol.233
, pp. 343-346
-
-
Clavel, F.1
Guétard, D.2
Brun-Vézinet, F.3
Chamaret, S.4
Rey, M.-A.5
Santos-Ferreira, M.O.6
Laurent, A.G.7
Dauguet, C.8
Katlama, C.9
Rouzioux, C.10
Klatzmann, D.11
Champalimaud, J.L.12
Montagnier, L.13
-
7
-
-
0005241362
-
Active human immunodeficiency virus protease is required for viral infectivity
-
(1988)
Proc. Natl. Acad. Sci. U.S.A.
, vol.85
, pp. 4686-4690
-
-
Kohl, N.E.1
Emini, E.A.2
Schleif, W.A.3
Davis, L.J.4
Heimbach, J.C.5
Dixon, R.A.F.6
Scolnick, E.M.7
Sigal, I.S.8
-
10
-
-
0029011730
-
Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections
-
(1995)
J. Med. Chem.
, vol.38
, pp. 2491-2517
-
-
De Clercq, E.1
-
15
-
-
0025952925
-
HIV protease: A novel chemotherapeutic target for AIDS
-
(1991)
J. Med. Chem.
, vol.34
, pp. 2305-2314
-
-
Huff, J.R.1
-
16
-
-
0025268321
-
Rational design of peptide-based HIV proteinase inhibitors
-
(1990)
Science
, vol.248
, pp. 358-361
-
-
Roberts, N.A.1
Martin, J.A.2
Kinchington, D.3
Broadhurst, A.V.4
Craig, J.C.5
Duncan, I.B.6
Galpin, S.A.7
Handa, B.K.8
Kay, J.9
Kröhn, A.10
Lambert, R.W.11
Merrett, J.H.12
Mills, J.S.13
Parkes, K.E.B.14
Redshaw, S.15
Ritchie, A.J.16
Taylor, D.L.17
Thomas, G.J.18
Machin, P.J.19
-
17
-
-
0029053608
-
Iterative protein structure-based drug design and synthesis of HIV protease inhibitors
-
(1995)
Eur. J. Med. Chem.
, vol.30
-
-
Kalish, V.1
Kaldor, S.2
Shetty, B.3
Tatlock, J.4
Davies, J.5
Hammond, M.6
Dressman, B.7
Fritz, J.8
Appelt, K.9
Reich, S.10
Musick, L.11
Wu, B.-W.12
Su, K.13
-
18
-
-
0028968902
-
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans
-
(1995)
Proc. Natl. Acad. Sci. U.S.A.
, vol.92
, pp. 2484-2488
-
-
Kempf, D.J.1
Marsh, K.C.2
Denissen, J.F.3
McDonald, E.4
Vasavanonda, S.5
Flentge, C.A.6
Green, B.E.7
Fino, L.8
Park, C.H.9
Kong, X.-P.10
Wideburg, N.E.11
Saldivar, A.12
Ruiz, L.13
Kati, W.M.14
Sham, H.L.15
Robins, T.16
Stewart, K.D.17
Hsu, A.18
Plattner, J.J.19
Leonard, J.M.20
Norbeck, D.W.21
more..
-
19
-
-
0028222149
-
L-735,-524: An orally bioavailable human immunodeficiency virus type I protease inhibitor
-
(1994)
Proc. Natl. Acad. Sci. U.S.A.
, vol.91
, pp. 4096-4100
-
-
Vacca, J.P.1
Dorsey, B.D.2
Schleif, W.A.3
Levin, R.B.4
McDaniel, S.L.5
Darke, P.L.6
Zugay, J.7
Quintero, J.C.8
Blahy, O.M.9
Roth, E.10
Sardana, V.V.11
Schlabach, A.J.12
Graham, P.I.13
Condra, J.H.14
Gotlib, L.15
Holloway, M.K.16
Lin, J.17
Chert, I.-W.18
Vastag, K.19
Ostovic, D.20
Anderson, P.S.21
Emini, E.A.22
Huff, J.R.23
more..
-
20
-
-
0027969994
-
L-735,524: The design of a potent and orally bioavailable HIV protease inhibitor
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3443-3451
-
-
Dorsey, B.D.1
Levin, R.B.2
McDaniel, S.L.3
Vacca, J.P.4
Guare, J.P.5
Darke, P.L.6
Zugay, J.A.7
Emini, E.A.8
Schleif, W.A.9
Quintero, J.C.10
Lin, J.H.11
Chen, I.-W.12
Holloway, M.K.13
Fitzgerald, P.M.D.14
Axel, M.G.15
Ostovic, D.16
Anderson, P.S.17
Huff, J.R.18
-
22
-
-
0028690038
-
Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease
-
(1994)
Methods Enzymol.
, vol.241
, pp. 334-354
-
-
Kempf, D.J.1
-
23
-
-
14444280615
-
2-symmetric HIV-1 protease inhibitors. Use of L-mannaric acid as a peptidomimetic scaffold
-
(1998)
J. Med. Chem.
, vol.41
, pp. 3782-3792
-
-
Alterman, M.1
Björsne, M.2
Mühlman, A.3
Classon, B.4
Kvaruström, I.5
Danielsson, H.6
Markgren, P.-O.7
Nillroth, U.8
Unge, T.9
Hallberg, A.10
Samuelsson, B.11
-
30
-
-
0344882737
-
Selective transformations of 2,3-epoxy alcohols and related derivatives. Strategies for nucleophilic attack at Carbon-3-or-Carbon-2
-
(1985)
J. Org. Chem.
, vol.50
, pp. 5696-5704
-
-
Behrens, C.H.1
Sharpless, K.B.2
-
31
-
-
0028143193
-
Inhibitors of HIV-1 proteinase containing 2-Heterosubstituted 4-Amino-3-hydroxy-5-phenylpentanoic Acid: Synthesis, enzyme inhibition, and antiviral activity
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3079-3089
-
-
Scholz, D.1
Billich, A.2
Charpiot, B.3
Ettmayer, P.4
Lehr, P.5
Rosenwirth, B.6
Schreiner, E.7
Gstach, H.8
-
32
-
-
0003275667
-
-
Unpublished results
-
-
-
Pyring, D.1
Rosenquist, Å.2
Zuccarello, G.3
Kvarnström, I.4
Zhang, H.5
Vrang, L.6
Lindberg, J.7
Unge, T.8
Hallberg, A.9
Classon, B.10
Samuelsson, B.11
-
36
-
-
0003102730
-
-
Unpublished test results by Medivir AB. Medivir@Medivir.se
-
-
-
|